CTLA4 and carcinoma: Spatial protein profiling corroborates these findings, revealing significantly decreased CD25+ and FOXP3+ Tregs in infiltrated stroma areas and CTLA4+ cells in both infiltrated stroma and carcinoma areas of GATA6high tumors.